This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
home-builder: Archive
Should You Buy DIRTT Environmental Solutions Ltd. (DRTTF) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DRTTFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Invesco SteelPath MLP Income C (MLPRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MLPRX
MLPRXPositive Net Change
equity home-builder mutual-funds
Is Fidelity Advisor Technology M (FATEX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FATEX
FATEXNo Net Change
equity home-builder mutual-funds
Is Wasatch Ultra Growth (WAMCX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for WAMCX
WAMCXPositive Net Change
equity home-builder mutual-funds
Is American Funds EuroPacific Growth R5 (RERFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for RERFX
RERFXPositive Net Change
equity home-builder mutual-funds
Should You Buy PLBY Group, Inc. (PLBY) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PLBYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Akamai Technologies (AKAM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AKAMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Allspring Pr Lrg Comp Grow R6 (EKJFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for EKJFX
EKJFXPositive Net Change
equity home-builder mutual-funds
Is American Funds Cap World Growth & Income A (CWGIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for CWGIX
CWGIXPositive Net Change
equity home-builder mutual-funds
Is ProFunds Internet UltraSector Service Class (INPSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for INPSX
INPSXNegative Net Change
equity home-builder mutual-funds
Is Shelton Nasdaq-100 Index Direct (NASDX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for NASDX
NASDXNegative Net Change
equity home-builder mutual-funds
Rate Cuts Back On? Markets Trade Like They Are
by Mark Vickery
News on a prospective new Fed Chair is giving market participants permission to price in multiple rate cuts once again, perhaps starting next month.
HPQNegative Net Change DELLNegative Net Change URBNPositive Net Change
consumer-discretionary earnings finance home-builder
Sinclair (SBGI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SBGINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is American Century Select Investor (TWCIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TWCIX
TWCIXPositive Net Change
equity home-builder mutual-funds
Revenge of Tech: AI, Crypto Bounce Back
by Mark Vickery
It was a strong bounce-back day for the tech space, with all "Mag 7" stocks up for the session.
ADPPositive Net Change ANFNegative Net Change BBYPositive Net Change ANegative Net Change DKSPositive Net Change TSLANegative Net Change MSTRNegative Net Change GOOGLPositive Net Change BABAPositive Net Change ZMPositive Net Change HOODNegative Net Change IBITNegative Net Change
artificial-intelligence cryptocurrency earnings home-builder retail tech-stocks
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PROFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Globus Medical (GMED) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GMEDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is ProFunds Semicond UltraSector Investor (SMPIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for SMPIX
SMPIXPositive Net Change
equity home-builder mutual-funds
Is Vanguard Tax-Managed Cap Appreciation Admiral (VTCLX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VTCLX
VTCLXPositive Net Change
equity home-builder mutual-funds
Is Vanguard Consumer Staples Index Admiral (VCSAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VCSAX
VCSAXNegative Net Change
equity home-builder mutual-funds
Qualys (QLYS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
QLYSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Putnam Focused Equity A (PGIAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PGIAX
PGIAXPositive Net Change
equity home-builder mutual-funds
Is Harbor Capital Appreciation Retirement (HNACX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for HNACX
HNACXNegative Net Change
equity home-builder mutual-funds
Is T. Rowe Price Blue Chip Growth Fund (TRBCX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TRBCX
TRBCXPositive Net Change
equity home-builder mutual-funds
Is American Funds Growth Portfolio A (GWPAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for GWPAX
GWPAXPositive Net Change
equity home-builder mutual-funds